about
Serious drug-induced liver disease secondary to ezetimibe.Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series.Liver transplantation across Rh blood group barriers increases the risk of biliary complications.Is retransplantation an option for recurrent hepatitis C cirrhosis after liver transplantation?Successful reuse of liver grafts after death of the first recipient.Sirolimus-based rescue therapy after rejection in liver transplantation.Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies.Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study.Clinical correlates of the "rods and rings" antinuclear antibody pattern.[Acute hepatitis and fever].Spontaneous bacterial peritonitis and bacterascites prevalence in asymptomatic cirrhotic outpatients undergoing large-volume paracentesis.Crohn's disease and the myelodysplastic syndrome.Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study.Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient.Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.Clinical features and outcome of spontaneous bacterial peritonitis in HIV-infected cirrhotic patients: a case-control study.Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.Rapid urease test: effect of preimmersion of biopsy forceps in formalin.Polymorphonuclear counts in ascitic fluid and microorganisms producing spontaneous bacterial peritonitis: an under-recognized relationship.Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.Spontaneous bacterial peritonitis and empyema by Escherichia coli resistant to norfloxacine in a patient on selective intestinal decontamination with norfloxacine.Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.Single-session endosonography and endoscopic retrograde cholangiopancreatography for biliopancreatic diseases is feasible, effective and cost beneficial.Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.Antral mass due to cytomegalovirus infection requiring gastrectomy in a liver transplant recipient.Fluoroscopy-assisted vs fluoroless endoscopic ultrasound-guided transmural drainage of pancreatic fluid collections: A comparative study.Reagent strips and spontaneous bacterial peritonitis.Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.Romiplostim in chronic liver disease with severe thrombocytopenia undergoing an elective invasive procedure.Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding.Spontaneous bacterial peritonitis and reagent strips.Use of reagent strips for the rapid diagnosis of spontaneous bacterial empyema.Acute tension hydrothorax: a life-threatening complication of cirrhosis.The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients.Endoscopic ultrasound-guided transesophageal drainage of a mediastinal pancreatic pseudocyst using a novel lumen-apposing metal stent.Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management.Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality.MIDODRINE &ALBUMIN for Preventing COMPLICATIONS IN PATIENTS WITH CIRRHOSIS AWAITING Liver transplantation
P50
Q33365589-096A2129-37A9-40BC-858E-7AEBD3877553Q33962491-1CCE1F0A-0011-4188-B0A1-F90D7B70AAF7Q35751557-6398CAA2-4CFA-449E-84AC-FE5310EA7E58Q36069059-3E902948-2A69-4CE3-8071-354041D892D0Q36591745-8E6A1B2B-4277-404A-BCDF-28532BD3532BQ37387752-F707E867-6BFF-402A-ADA1-04817F5BC540Q40100867-FF0BB3A3-00AD-4EA2-80D2-161B05A61D27Q40132502-903A989D-C80D-427F-85CE-73C797658381Q40162171-70C3A75F-4500-47DB-89B1-A9F15DCC45DFQ40176558-E4A89F47-763E-4EA7-BBA3-2699C2BF3784Q40361688-C3B583DB-34BA-4023-BBEB-E556125AFB78Q40442546-82B6954C-3A58-4A5D-9F60-7DE9CF502E81Q41558785-281C000A-BA1B-464D-8346-20660AB8DE27Q42983282-75BACF4F-7212-4329-B027-E1C3CF787A51Q42994735-4AECEE37-E0B6-49BC-8CF3-25DA12EA4B8AQ42998374-06E2AC5D-662C-4301-94CF-8D488EF1D46DQ43000726-76FB55B8-D1CC-45CB-9072-83633705B0F8Q43606043-BE2E6608-CB80-4838-9516-CF8B47B8C043Q43619111-29B1DA20-2CDC-414B-88F5-0026F3604C5BQ43959122-E8886F13-0221-4F75-92D3-DA5D7E59FB8AQ44100013-EB86E8DD-5D61-4F80-89CF-67A83A2FDBD3Q44544778-7F3C0F03-1954-44D8-AC1F-0B787F603646Q44642141-C49FB771-0C85-4469-8D14-720DA9B1CAC0Q45835814-4A43C007-7A18-478F-9548-D61E6B7E690DQ46109395-22A6581A-1879-40FC-8C1F-8D6CE4FE6497Q46657609-60011394-F423-49E7-A253-CC51D23EB511Q47255284-A6D6A1C4-35D1-4264-BC9F-C65A107DE04FQ47401773-A8386A92-5C03-484A-BAEF-018236223425Q47895423-D60B1CDE-8619-45F5-9D1B-4710CE52F3C3Q48553825-D6691BC4-28D0-468A-957A-37B1604B4CACQ50207345-61D3381D-2C2A-4257-A15F-7A3D9D20DDFCQ50875705-79E2A294-4963-446F-B544-808A7D13AC63Q51531037-96318315-BC0C-44CB-85B3-F5D3D73A00ADQ51720217-5D940A6D-4DCC-4F48-9557-D14F8C9C13CDQ51747581-0429E053-30EF-4036-8A47-2AA06F0C1191Q52744464-D7A3AFA1-28D1-46B8-8E3B-015D7F516C9CQ53160275-D049D523-0BA7-46A7-AAC5-9F288E608760Q53325421-17BB4641-2568-4654-806A-94D8F5FC6CA4Q53454698-416E9177-F503-4C0D-8489-2F382D932E0AQ56516206-A787880A-A28D-42CF-970F-A97F7BF1C47C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jose Castellote
@ast
Jose Castellote
@en
Jose Castellote
@es
Jose Castellote
@nl
type
label
Jose Castellote
@ast
Jose Castellote
@en
Jose Castellote
@es
Jose Castellote
@nl
prefLabel
Jose Castellote
@ast
Jose Castellote
@en
Jose Castellote
@es
Jose Castellote
@nl
P106
P1153
6507774427
7003803745
P21
P31
P496
0000-0002-8528-3112